logo
Why are young, active adults facing fatal heart issues? The silent cardiac crisis striking healthy youth

Why are young, active adults facing fatal heart issues? The silent cardiac crisis striking healthy youth

Time of India3 days ago
It used to be rare—almost unthinkable. A 25-year-old collapsing in the gym, a 30-something IT professional dying in his sleep, a teenage athlete suffering cardiac arrest mid-game. But today, these stories are no longer shocking. They're becoming heartbreakingly routine.
A wave of sudden cardiac deaths among young adults is sweeping across India and the world—and the big question is: Why?
Explore courses from Top Institutes in
Select a Course Category
others
CXO
PGDM
Project Management
Design Thinking
Public Policy
Leadership
Management
Digital Marketing
Degree
Cybersecurity
Healthcare
Data Analytics
healthcare
MBA
Artificial Intelligence
Product Management
Technology
MCA
Data Science
Others
Data Science
Operations Management
Skills you'll gain:
Duration:
16 Weeks
Indian School of Business
CERT - ISB Cybersecurity for Leaders Program India
Starts on
undefined
Get Details
Skills you'll gain:
Duration:
16 Weeks
Indian School of Business
CERT - ISB Cybersecurity for Leaders Program India
Starts on
undefined
Get Details
Experts are ringing alarm bells, and it's time we all listened.
The Startling Shift: From Rare Tragedies to Daily Headlines
According to a report from Times of India citing Dr. Girish B Navasundi, Senior Consultant in Interventional Cardiology at
Apollo Hospitals
, 'We're seeing people who appear healthy—students, professionals, even athletes—suddenly dying of cardiac arrest. It wasn't this common earlier.'
So what changed? Why are people under 40—who should be in the prime of their lives—suffering fatal heart events?
You Might Also Like:
Shefali Jariwala's shocking death at 42: Apollo doctor explains why younger Indians are vulnerable to heart attacks and reveals silent symptoms
The answer lies in a perfect storm of genetics, lifestyle stressors, and post-COVID complications—all converging to make young hearts more vulnerable than ever before.
Cardiac Arrest ≠ Heart Attack: Know the Difference
First, let's clear the confusion:
A heart attack happens when blood flow to the heart is blocked—often due to clogged arteries.
A cardiac arrest is electrical—your heart suddenly stops beating, and death can occur within minutes.
While a heart attack might show signs like chest pain or discomfort, cardiac arrest often strikes without warning, leaving victims with little to no time to react.
You Might Also Like:
How being in love can actually boost your heart health, according to cardiologists
The Silent Risks Lurking in Young Bodies
Behind many cases of
sudden cardiac death
are undiagnosed conditions.
Hypertrophic Cardiomyopathy
(HCM): A thickening of the heart muscle that often goes unnoticed.
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): A rare genetic disorder affecting heart rhythm.
Congenital Heart Defects: Present from birth but may only show symptoms later in life.
According to the Cleveland Clinic, such heart abnormalities are now surfacing in people as young as 15.
But there's more: COVID-19 has left behind a trail of cardiovascular complications.
Even asymptomatic or mildly affected young people have reported myocarditis (inflammation of the heart muscle), which can lead to fatal arrhythmias.
A Heart Under Constant Attack
Poor diet and sedentary habits
Overconsumption of processed foods and energy drinks
Late-night work, screen time, and poor sleep
Extreme or unsupervised workouts without rest
Supplements and steroids used for quick fitness gains
Add to this the invisible burden of chronic stress.
As Dr. Navasundi explained: 'Mental and emotional stress raises blood pressure, disrupts sleep, inflames the body. The heart doesn't get rest—it's always in fight mode.'
Stress has become so normalized among the youth that palpitations, anxiety, and fatigue are often ignored until it's too late.
The Symptoms That Shouldn't Be Dismissed
Cardiac arrests may be sudden—but the body often whispers before it screams. Watch out for:
Shortness of breath
Dizziness or blackouts
Unexplained fatigue
Chest pain or tightness
Heart palpitations
These symptoms are often misattributed to 'overwork,' 'gym soreness,' or 'just stress.' But in reality, they could be your heart crying for help.
According to the Journal of the American Heart Association, the survival rate for out-of-hospital cardiac arrests is just 10%. That's why bystander CPR can double or triple survival chances.
Sadly, India ranks low in CPR awareness. Knowing how to respond in those critical first minutes—before an ambulance arrives—can mean the difference between life and death.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Int'l genetic study predicts childhood obesity risk using Indian data
Int'l genetic study predicts childhood obesity risk using Indian data

Time of India

time6 hours ago

  • Time of India

Int'l genetic study predicts childhood obesity risk using Indian data

Cleared: dk Hyderabad: In a major study, an international team of over 600 scientists from 500 institutions developed a genetic test — polygenic risk score (PRS) — which can predict adult obesity as early as age five. The study analysed data from over five million (50 lakh) individuals worldwide, with significant representation from India. Scientists from city-based Centre for Cellular and Molecular Biology (CCMB) played a key role in characterising the genomes of Indian individuals, including those monitored for diabetes over the long term. The south Asian data shaped PRS, making the findings especially relevant to the Indian context, where obesity-related disorders like diabetes and cardiovascular disease are on the rise. The tool, shown to be twice as effective as previous models, offers the potential for early lifestyle interventions in genetically high-risk children. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad CCMB researchers on Tuesday said that obesity increases the risk of non-communicable diseases such as diabetes, cardiovascular diseases, poor bone health, reproductive problems, and cancers. Scientists worldwide worked with the largest and most diverse genetic dataset ever assembled, which included genetic data from the GIANT consortium and the consumer DNA testing company 23andMe. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 15 most beautiful women in the world Undo In a statement, CCMB said: "The PRS discovery could help identify children and adolescents already at higher genetic risk of developing obesity, who could benefit from targeted preventative strategies such as lifestyle interventions at a younger age. Additionally, this score is twice as effective as the previous best test at predicting a person's risk of developing obesity." "What makes the score so powerful is its ability to predict, around the age of five, whether a child is likely to develop obesity in adulthood — well before other risk factors start to shape their weight later in childhood. Intervening at this point can have a huge impact," University of Copenhagen's NNF Center for Basic Metabolic Research (CBMR) assistant professor Roelof Smit, who is the lead author of the research published in the journal 'Nature Medicine', said. Indian Representation in the Study The pattern of obesity in India differs notably from that in Europe, with Indians tending to have more central (abdominal) obesity. Earlier studies by Dr Giriraj Ratan Chandak at CCMB showed that the genetic basis of non-communicable diseases varies significantly between Indians and Europeans. In the latest study, researchers at CCMB, led by Dr Chandak, characterised the genomes of the Indian population, including individuals with diabetes as well as those with normal blood glucose levels. These individuals were followed for nearly 20 years, providing a unique opportunity to investigate the genetic basis of obesity in Indians. Several obesity-associated genetic changes were identified and used to develop PRS for Indians, effectively creating a "virtual individual" to model obesity risk. The Indian data served as a representative subset for the South Asian population in the global study, making the findings more applicable to India and neighbouring countries. The researchers also examined the link between a person's genetic risk of obesity and the effectiveness of lifestyle-based weight-loss interventions, such as diet and exercise. They found that individuals with a higher genetic risk of obesity responded better to interventions — but also tended to regain weight more quickly once those interventions ended. The study further highlights the role of population ancestry in predicting obesity risk. Despite using a globally representative dataset, PRS performed more accurately in individuals of European ancestry than in those of other ancestries, including South Asians. Many gene variants associated with obesity in Europeans do not have the same effect in Indians, reflecting the unique pattern of obesity observed in the Indian population. "The observations made in this study are consistent with our earlier findings," Dr Chandak noted.

Potential US tariff a significant 'unknown' for business, says Dr Reddy's Lab CEO
Potential US tariff a significant 'unknown' for business, says Dr Reddy's Lab CEO

Time of India

time13 hours ago

  • Time of India

Potential US tariff a significant 'unknown' for business, says Dr Reddy's Lab CEO

A potential US tariff on the pharma sector is a significant 'unknown' and will be one of the key developments for Dr Reddy's Laboratories to watch over the next few quarters, its chief executive officer, Erez Israeli , told ET. 'Don't know whether to call it a risk, but it is an unknown that could develop into a risk, and that is the tariff. We will know better as time will come about what it means and what we can do,' Israeli said over an earning call on Wednesday. 'It's not necessarily bad, it can also create an opportunity. It very much depends on what will be our relative situation to Chinese players or others.' Explore courses from Top Institutes in Please select course: Select a Course Category Technology Leadership Project Management Healthcare Management Data Analytics Data Science others Cybersecurity Artificial Intelligence Design Thinking Degree Product Management Public Policy Data Science MCA Finance MBA Others healthcare Operations Management PGDM CXO Digital Marketing Skills you'll gain: Duration: 12 Weeks MIT xPRO CERT-MIT XPRO Building AI Prod India Starts on undefined Get Details The Hyderabad-based drug maker, which announced its first-quarter earnings, is betting big on generic version of Novo Nordisk 's weight loss molecule semaglutide – that it plans to launch in 87 countries in 2026 - as a future growth driver. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo 'Our levers for the future consist of double-digit growth of the main business and then on top of it the success of semaglutide, which is very important to us, business development and our ability to optimise our resources,' Israeli said in response to ET's query. 'We are planning to launch semaglutide in 87 countries as the patent in the relevant country will allow us… We have some countries where there is no active patent as we speak, and in those we can launch. In the other countries, we need to wait for the patent expiration - for example Brazil or India - in which the patent goes on till March 2026. We are absolutely ready to launch on day 1 (post patent expiry) in each one of these markets,' he said. Live Events The company which is among the frontrunners for GLP-1 drugs is looking at launching 26 other products in the space over the next decade. 'We have 26 products (all peptides) in the GLP1 pipeline and will be launched over the next decade, according to the patent situation,' said Israeli. On Wednesday, the company reported consolidated revenue for the first quarter at Rs 8,545 crore, an 11% increase from a year ago, mainly on account of contributions from its acquired consumer healthcare portfolio in nicotine replacement therapy (NRT) and sustained performance in branded markets. Net profit for the quarter stood at Rs 1,418 crore, up 2% y-o-y. Israeli said an ongoing litigation over semaglutide with innovator company Novo Nordisk in India is not likely to hamper its planned product launches. The company's global generics revenue in Q1FY26 stood at Rs 7,562 crore, a growth of 10% year-on-year. However, revenue from North America–one of its key markets–declined 11% y-o-y to Rs 3,412 crore due to increased price erosion in select products, including lenalidomide. Its Europe revenue stood at Rs 1,274 crore, up 142% on account of NRT portfolio acquisition. The company's India and emerging markets business grew 11% and 17% respectively. The company's EBITDA margin for the first quarter stood at 26.7%.

WHO sees 'deadly' surge in malnutrition in Gaza; 21 children under five killed in 2025
WHO sees 'deadly' surge in malnutrition in Gaza; 21 children under five killed in 2025

Time of India

time14 hours ago

  • Time of India

WHO sees 'deadly' surge in malnutrition in Gaza; 21 children under five killed in 2025

The World Health Organization said on Wednesday it was seeing a deadly surge in malnutrition in Gaza that has led to the deaths of 21 children under five so far in 2025. Malnutrition centers are full without sufficient supplies for emergency feeding, the health agency said, as the hunger crisis gets accelerated by the collapse of aid pipelines and restrictions on access. Explore courses from Top Institutes in Please select course: Select a Course Category Leadership Finance Operations Management Artificial Intelligence Cybersecurity Data Analytics Public Policy Management Design Thinking Product Management Technology Data Science Others Healthcare MBA Digital Marketing healthcare MCA CXO others Project Management Data Science PGDM Degree Skills you'll gain: Duration: 18 Weeks 109820388 Strategic Marketing for Leaders: Leveraging AI for Growth Starts on undefined Get Details Skills you'll gain: Duration: 22 Weeks Indian School of Business SEPO - ISB Venture Capital & Private Equity India Starts on undefined Get Details Skills you'll gain: Duration: 10 Months IIM Kozhikode CERT-IIMK-Women Leadership Programme INDIA Starts on undefined Get Details Skills you'll gain: Strategic Thinking & Planning Competitive Advantage & Market Positioning Strategic Leadership & Decision-Making Change Management & Organizational Transformation Duration: 1 Year IIM Kozhikode IIMK Advanced Strategic Management Programme Starts on Mar 30, 2024 Get Details Skills you'll gain: Duration: 12 Months IIM Kozhikode Advanced Strategic Management Programme Starts on undefined Get Details Skills you'll gain: Opportunities & Outlining Plans to use AI & ML Applying Data-Driven Business Innovation Best Practices Changing Culture to Integrate AI-Enabled Technologies Ethics, Privacy and Regulations in AI & ML Duration: 20 Weeks Indian School of Business ISB Leadership in AI Starts on May 14, 2024 Get Details Skills you'll gain: Duration: 12 Months IIM Kozhikode SEPO - IIMK CEO Programme India Starts on undefined Get Details Skills you'll gain: Critical Thinking & Decision-Making Skills Power of Emerging Technologies Innovation and Drive Organizational Change Fostering a Culture of Innovation Duration: 9 Months MIT xPRO MIT Technology Leadership and Innovation Starts on May 14, 2024 Get Details Skills you'll gain: Duration: 12 Weeks IIM Kozhikode CERT-IIMK EPIS Async India Starts on undefined Get Details Skills you'll gain: Duration: 12 Months IIM Kozhikode Senior Management Programme Starts on undefined Get Details Skills you'll gain: Duration: 10 Months IIM Indore Executive Programme in Business Management Starts on undefined Get Details Skills you'll gain: Duration: 11 Months IIM Lucknow CERT-IIML SLP India Starts on undefined Get Details Skills you'll gain: Financial Accounting & Analysis Financial Instruments & Markets Corporate Finance & Valuation Investment Management & Banking Duration: 12 Months IIM Kozhikode IIMK Professional Certificate in Financial Analysis and Financial Management Starts on Mar 30, 2024 Get Details Gaza has seen its food stocks run out since Israel cut off all supplies to the territory in March and then lifted that blockade in May, but with conditions that it says are needed to prevent aid from being diverted to militant groups. However, aid agencies say that only a trickle of what is needed is currently reaching people in Gaza. WHO Director-General Tedros Adhanom Ghebreyesus said the health agency was unable to deliver any food for nearly 80 days between March and May, adding that the resumption of deliveries was still far below what is needed. "The 2.1 million people up in the war zone that is Gaza are facing yet another killer on top of bombs and bullets, starvation; we're now witnessing a deadly surge in malnutrition related disease," Ghebreyesus said. Live Events

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store